They appear to downregulate epidermal growth factor receptor (EGFR), protein kinase C (PKC), Ras, NF-κB, and insulin-like growth factor (IGF), which are important cell-signaling mediators often found to be elevated in cancer. The gene discussed is NFKB1; the disease is cancer.